CBD: Stanford University Scientists Launch Medical Marijuana Pharma Co For Manufacturing Drugs For Treating Incurable Neurodegenerative & Inflammatory Diseases

Stanford University scientists, Dr. Jonathan Rothbard, and Professor Lawrence Steinman have launched Katexco Pharmaceuticals, a medical marijuana company. According to the media reports, the newly launched Katexco Pharmaceuticals will produce CBD-based drugs that would exploit endocannabinoid and nicotine receptors in the brain for treating several neurodegenerative & inflammatory diseases where conventional medicines have failed. Cannabis-based … Continue reading CBD: Stanford University Scientists Launch Medical Marijuana Pharma Co For Manufacturing Drugs For Treating Incurable Neurodegenerative & Inflammatory Diseases